Peter David Suzdak Insider Trading $RNN Ocuphire Pharma, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter David Suzdak.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter David Suzdak. Peter David Suzdak is Chief Executive Officer in REXAHN PHARMACEUTICALS, INC. ($RNN).

Peter David Suzdak in Ocuphire Pharma, Inc.

Trading Symbol: RNN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter David Suzdak: Chief Executive Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 27 2015
$RNN Market Capitalization: $41.78M
$RNN Previous Close: $0.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Peter David Suzdak in Ocuphire Pharma, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 27 2015RNNREXAHN PHARMACEUTI ...Suzdak Peter DavidChief Executive Off ...Option ExerciseA0.711,100,000781,0001,100,000
Sep 05 2014RNNREXAHN PHARMACEUTI ...Suzdak Peter DavidChief Executive Off ...Option ExerciseA0.831,000,000830,0001,000,000
Jan 14 2014RNNREXAHN PHARMACEUTI ...Suzdak Peter DavidChief Executive Off ...Option ExerciseA1.14350,000399,000350,000
Feb 06 2013RNNREXAHN PHARMACEUTI ...Suzdak Peter DavidChief Executive Off ...Option ExerciseA0.371,200,000444,0001,200,000

Page:   1